New patent for Reata Pharms drug SKYCLARYS

Annual Drug Patent Expirations for SKYCLARYS Skyclarys is a drug marketed by Reata Pharms and is included in one NDA. It is available from one supplier. There are six patents…

Source


Comments are closed.

Biotechblog